1 / 20

First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel Kuwait

First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel Kuwait. Access to medicine is essential for better outcome Dr. Jaroslav Nemec Consultant Medical Oncologist Head of GI Unit, Medical Oncology Department - KCCC.

rcrayton
Download Presentation

First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel Kuwait

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. First HAYAT Annual Patients Forum 21st March 2010 Al Hashimi II Ballroom – SAS Hotel Kuwait

  2. Access to medicine is essential for better outcome Dr. Jaroslav Nemec Consultant Medical Oncologist Head of GI Unit, Medical Oncology Department - KCCC

  3. Many cancer patients require surgery and radiotherapy and medical therapy All medicines we use have been scientifically proven to be effective and beneficial Cancer Therapy

  4. All anticancerous medicines are expensive Prices ranging from dozens to thousands KD monthly Some patients may require medicines for years Cancer Therapy

  5. Medicines may cure some cancers, or extend the life of incurable patients Access to medicines is critical for cure or extending the lives Cancer Therapy

  6. Almost all cancer medicines in Kuwait are granted for all patients Only few expensive medicines may not be provided for non-Kuwaiti patients HERE THE HAYAT FUND COMES Cancer Therapy

  7. HOW TO USE THE HAYAT SUPPORT FOR THE BEST BENEFIT OF OUR PATIENTS SHARING DOCTOR’S THOUGHTS

  8. All medicines we use have been rigorously tested to be proven beneficial More expensive not always means more beneficial Some expensive medicines save lives, some add little SHARING DOCTOR’S THOUGHTS

  9. Selecting the patients who would benefit most Selecting the medicines wisely = those providing most of the benefit MEDICAL ONCOLOGY DEPARTMENT POLICY

  10. HAYAT Supports several expensive drugs used at the Medical Oncology Department for different cancers MEDICAL ONCOLOGY DEPARTMENT POLICY

  11. Class: Molecular targeted agents Used for a specific type of breast cancer, specially tested for benefit from the drugs Injections and tablets Cost: 1000-1500 KD monthly. Many patients would be on treatment for more than a year, even few years. BREAST CANCER

  12. Benefit from the drugs: After operation, the risk of cancer returning is reduced In advanced breast cancer, these drugs improve benefit from chemotherapy and hormonal therapy (more patients would experience tumor shrinkage and live longer) and reduces symptoms induced by the disease BREAST CANCER

  13. Class: Hormonal therapy Used for a specific type of breast cancer, specially tested for benefit from the drugs Tablets Cost: 95 KD/month, 1140 KD/year. Many patients would be on treatment for more than a year, even few years. BREAST CANCER

  14. Benefit from the drug: After operation, the risk of cancer returning is reduced In advanced breast cancer, the drug prolongs the life and reduces symptoms induced by the disease BREAST CANCER

  15. Class: monoclonal antibody Used in some specific types of non-Hodgkin’s lymphoma, in combination with chemotherapy or alone Cost: One dose = about 800 KD, total cost varies according to the schedule, may exceed 7,000 KD NON-HODGKIN’S LYMPHOMA

  16. Benefit from the drug: More patients would be cured with chemotherapy In patients who can’t be cured, the drug prolongs the life and reduces symptoms induced by the disease NON-HODGKIN’S LYMPHOMA

  17. 1) The drug controlling vessels supplying the tumor with blood Effective in colon, lung, ovarian, breast, brain cancers. Cost: May differ in different cancers. Around 1300 KD/months, 4000 KD/3 months Benefit: Improves benefit from chemotherapy, prolongs life in some cancers, reduces problems from disease MEDICINES SUPPORTED BY HAYAT FUND USED IN DIFFERENT CANCERS

  18. 2) The drugs used in lung, pancreatic, liver, kidney cancers and rare diseases of digestive tract: Different classes of drugs Don’t cure the disease May prolong life, prolong time the tumor is not growing, control symptoms of cancer Cost: Very different. 1000 – 2000 KD/month, used for several months, some for several years. MEDICINES SUPPORTED BY HAYAT FUND USED IN DIFFERENT CANCERS

  19. SUPPORT FROM HAYAT FUND IS CRITICAL FOR MANY OF OUR PATIENTS USING THE SUPPORT WISELY AND EFFECTIVELY IS DOCTORS’ CONTRIBUTION

  20. Thank You Dr. Jaroslav Nemec Consultant Medical Oncologist Head of GI Unit, Medical Oncology Department - KCCC

More Related